Latest filing published 18 Sept 2025 for Y-mAbs Therapeutics, Inc., €42k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ashu Tyagi: trading record in brief
This profile gathers the share dealings of Ashu Tyagi in Y-mAbs Therapeutics, Inc. In total, 6 filings cover trades dated from 25 September 2018 to 16 September 2025.
Purchases make up the whole of the open-market record (1 purchase, €5.9M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants.
The newest entry dates from 18 September 2025: a transaction, in Y-mAbs Therapeutics, Inc. The last insider purchase was made public on 26 September 2018, 2,965 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ashu Tyagi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,825 shares@ US$8.60Common StockSEC:0001752467-25-000005:0
- 25,080 shares0Common StockSEC:0001415889-25-019049:0
- 3,495 shares0Common StockSEC:0001104659-24-071398:0
- 2,330 shares0Common StockSEC:0001104659-23-070041:0
4 of 4 declarations